67750 Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices 

5350; telephone number: (410) 305– 

2637; email address: smith.lisas@

epa.gov. 

For information on the draft guidance 

contact: Ce ́sar E. Cordero, Efficacy 

Branch (7510M), Antimicrobials 

Division, Office of Pesticide Programs, 

Environmental Protection Agency, 

William Jefferson Clinton East Building, 

1200 Pennsylvania Ave. NW, 

Washington, DC 20460; telephone 

number: (202) 564–3716; email address: 

cordero.cesar@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general; although this action may be 

of particular interest to those persons 

who are or may be required to conduct 

efficacy testing of chemical substances 

under the Federal Insecticide, 

Fungicide, and Rodenticide Act 

(FIFRA). Since other entities may also 

be interested, the Agency has not 

attempted to describe all the specific 

entities that may be affected by this 

action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the person 

listed under FOR FURTHER INFORMATION

CONTACT. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not CBI to EPA 

through https://www.regulations.gov or 

email. If you wish to include CBI in 

your comment, please follow the 

applicable instructions at https://

www.epa.gov/dockets/commenting-epadockets#rules and clearly mark the part 

or all of the information that you claim 

to be CBI. In addition to one complete 

version of the comment that includes 

information claimed as CBI, a copy of 

the comment that does not contain the 

information claimed as CBI must be 

submitted for inclusion in the public 

docket. Information so marked will not 

be disclosed except in accordance with 

procedures set forth in 40 CFR part 2. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

https://www.epa.gov/dockets/ 

commenting-epa-dockets. 

II. Background 

Legionella pneumophila is a 

bacterium that is often identified as the 

causative agent of Legionnaires’ Disease, 

which is a disease acquired by inhaling 

water droplets contaminated with 

Legionella bacteria. Legionellae are 

found naturally in freshwater 

environments but can become a health 

concern when they grow and spread in 

human-made building water systems 

like cooling towers. Cooling towers are 

a potential breeding ground for L. 

pneumophila and subsequent 

aerosolization of L. pneumophila can 

occur if cooling towers are not properly 

disinfected and maintained. Following a 

Legionnaires’ disease outbreak in New 

York City in 2015, New York State 

began requiring cooling towers to be 

registered with the state and monitored 

and treated for L. pneumophila. 

However, EPA currently does not have 

guidance providing a framework for 

those seeking to register antimicrobial 

products with public health claims to 

reduce Legionella in cooling tower 

water. EPA received requests to develop 

a test method and guidance for 

registration of antimicrobial products 

intended to reduce L. pneumophila in 

water used in cooling tower systems. 

There is significant interest from 

stakeholders and the public in the 

availability of antimicrobial products 

with these claims. 

III. Guidance Documents Do Not 

Contain Binding Requirements 

As guidance, these documents are not 

binding on the Agency or any outside 

parties, and the Agency may depart 

from these documents where 

circumstances warrant and without 

prior notice. While EPA has made every 

effort to ensure the accuracy of the 

discussion in the guidance, the 

obligations of EPA and the regulated 

community are determined by statutes, 

regulations, or other legally binding 

documents. In the event of a conflict 

between the discussion in the guidance 

documents and any statute, regulation, 

or other legally binding document, the 

guidance documents will not be 

controlling. 

Authority: 7 U.S.C. 136 et seq. 

Dated: September 26, 2023. 

Michal Freedhoff, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2023–21643 Filed 9–29–23; 8:45 am] 

BILLING CODE 6560–50–P 

EQUAL EMPLOYMENT OPPORTUNITY 

COMMISSION 

[Agency Docket No: EEOC–2023–0005] 

RIN: 3046–ZA02 

Proposed Enforcement Guidance on 

Harassment in the Workplace 

AGENCY: Equal Employment 

Opportunity Commission. 

ACTION: Notice of availability and 

request for comment. 

SUMMARY: The Equal Employment 

Opportunity Commission (‘‘EEOC’’) is 

announcing that its proposed 

‘‘Enforcement Guidance on Harassment 

in the Workplace’’ is available for public 

comment. 

DATES: Comments must be received on 

or before November 1, 2023. Please see 

the sections below entitled ADDRESSES

and SUPPLEMENTARY INFORMATION for 

additional information on submitting 

comments. 

ADDRESSES: You may submit comments, 

identified by docket number EEOC– 

2023–0005 or Regulatory Information 

Number (RIN) 3046–ZA02, by any of the 

following methods—please use only one 

method: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Fax: 202–663–4114. Only 

comments of six or fewer pages will be 

accepted via FAX transmittal, in order 

to assure access to the equipment. 

Receipt of FAX transmittals will not be 

acknowledged, except that the sender 

may request confirmation of receipt by 

calling the Executive Secretariat staff at 

202–921–2815 (voice), 1–800–669–6820 

(TTY), or 1–844–234–5122 (ASL video 

phone). 

• Mail: Raymond Windmiller, 

Executive Officer, Executive Secretariat, 

U.S. Equal Employment Opportunity 

Commission, 131 M Street NE, 

Washington, DC 20507. 

• Hand Delivery/Courier: Raymond 

Windmiller, Executive Officer, 

Executive Secretariat, U.S. Equal 

Employment Opportunity Commission, 

131 M Street NE, Washington, DC 

20507. 

Instructions: The Commission invites 

comments from all interested parties. 

All comment submissions must include 

the agency name and docket number 

(EEOC–2023–0005) or RIN (3046–ZA02) 

for this guidance. Comments need be 

submitted in only one of the abovelisted formats. All comments received 

will be posted without change to 

https://www.regulations.gov, including 

any personal information you provide. 

However, the EEOC reserves the right to 

refrain from posting libelous or 

otherwise inappropriate comments, 

including those that contain obscene, 

indecent, or profane language; that 

contain threats or defamatory 

statements; that contain hate speech 

directed at race, color, sex, national 

origin, age, religion, disability, or 

genetic information; or that promote or 

endorse services or products. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices 67751 

Docket: For access to the docket to 

read background documents or 

comments received, go to https://

www.regulations.gov and search for 

‘‘EEOC–2023–0005’’ or ‘‘RIN 3046– 

ZA02.’’ The received comments also 

will be available for review at the 

Commission’s library, 131 M Street NE, 

Suite 4NW08R, Washington, DC 20507, 

between the hours of 9:30 a.m. and 5:00 

p.m., from November 1, 2023 until the 

Commission publishes the guidance in 

final form. You must make an 

appointment with library staff to review 

the comments in the Commission’s 

library. 

FOR FURTHER INFORMATION CONTACT: 

Lynn Davenport, Assistant Legal 

Counsel, lynn.davenport@eeoc.gov; 

Office of Legal Counsel, 202–856–7072 

(voice), 1–800–669–6820 (TTY). 

SUPPLEMENTARY INFORMATION: 

Background 

The EEOC is seeking public 

comments on all aspects of its proposed 

‘‘Enforcement Guidance on Harassment 

in the Workplace’’ (proposed guidance) 

pursuant to 29 CFR part 1695. The 

proposed guidance presents a legal 

analysis of standards for harassment and 

employer liability applicable to claims 

of harassment under the equal 

employment opportunity statutes 

enforced by the Commission. The 

Commission posted and requested 

public input on a proposed guidance on 

workplace harassment in January 2017, 

which was not finalized. 

The contents of the final guidance 

document will not have the force and 

effect of law and are not meant to bind 

the public in any way. The document is 

intended only to provide clarity to the 

public regarding Commission policies 

and existing requirements under the 

law. The standards discussed under 

EEOC-enforced laws will not necessarily 

apply to allegations of unlawful 

harassment under other Federal laws or 

under State or local laws. 

For the Commission: 

Charlotte A. Burrows, 

Chair. 

[FR Doc. 2023–21644 Filed 9–29–23; 8:45 am] 

BILLING CODE 6570–01–P 

FARM CREDIT SYSTEM INSURANCE 

CORPORATION 

Board of Directors Meeting 

SUMMARY: Notice of the forthcoming 

regular meeting of the Board of Directors 

of the Farm Credit System Insurance 

Corporation (FCSIC), is hereby given in 

accordance with the provisions of the 

Bylaws of the FCSIC. 

DATES: 10 a.m., Wednesday, October 11, 

2023. 

ADDRESSES: You may observe the open 

portions of this meeting in person at 

1501 Farm Credit Drive, McLean, 

Virginia 22102–5090, or virtually. If you 

would like to virtually attend, at least 24 

hours in advance, visit FCSIC.gov, select 

‘‘News & Events,’’ then select ‘‘Board 

Meetings.’’ From there, access the 

linked ‘‘Instructions for board meeting 

visitors’’ and complete the described 

registration process. 

FOR FURTHER INFORMATION CONTACT: If 

you need more information or assistance 

for accessibility reasons, or have 

questions, contact Ashley Waldron, 

Secretary to the Board. Telephone: 703– 

883–4009. TTY: 703–883–4056. 

SUPPLEMENTARY INFORMATION: Parts of 

this meeting will be open to the public. 

The rest of the meeting will be closed 

to the public. The following matters will 

be considered: 

Portions Open to the Public 

• Approval of Minutes for July 12, 2023 

• Quarterly FCSIC Financial Reports 

• Quarterly Report on Insured 

Obligations 

• Quarterly Report on Annual 

Performance Plan 

• Annual Performance Plan 

• Budget 2024–2025 

Portions Closed to the Public 

• Confidential Report on Insurance Risk 

Ashley Waldron, 

Secretary to the Board. 

[FR Doc. 2023–21681 Filed 9–29–23; 8:45 am] 

BILLING CODE 6705–01–P 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y, (12 

CFR part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors, 

Ann E. Misback, Secretary of the Board, 

20th Street and Constitution Avenue 

NW, Washington DC 20551–0001, not 

later than October 17, 2023. 

A. Federal Reserve Bank of New York 

(Ivan J. Hurwitz, Head of Bank 

Applications) 33 Liberty Street, New 

York, New York 10045–0001. Comments 

can also be sent electronically to 

comments.applications@ny.frb.org: 

1. The Goldman Sachs Group, Inc., 

New York, New York; to engage in 

community development activities 

pursuant to section 225.28(b)(12) of the 

Board’s Regulation Y. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–21737 Filed 9–29–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Advisory 

Committee on Breast Cancer in Young 

Women (ACBCYW) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

ACBCYW. The ACBCYW consists of 15 

experts in fields associated with breast 

cancer, disease prevention, early 

detection, diagnosis, public health, 

social marketing, genetic screening and 

counseling, treatment, rehabilitation, 

palliative care, and survivorship in 


lotter on DSK11XQN23PROD with NOTICES1